title: The release of nitroglycerin absorbed into the central venous catheter.
abstract: This study was conducted to evaluate the release of nitroglycerin (NG) that has been absorbed into the central venous catheter. A 0.05% NG solution was infused through a central venous catheter and the flow rates were set at 1, 5, or 10 ml/h, given over 12, 24, or 48 h. The catheter was flushed with lactate Ringer solution after completion of the NG infusion. The elution of the lactate Ringer solution from the tip of the catheter was then collected and assayed for its NG concentration by high performance liquid chromatography (HPLC). A higher concentration of NG was released with a faster flow rate and a longer infusion. The high level of NG release continued during the first 20 min, and ranged from a minimum of 0.07 mg/ml to a maximum that exceeded 0.15 mg/ml. Subsequently, the NG concentration gradually declined, but low concentrations of 0.006-0.02 mg/ml were still maintained 360 min later. Thus, it is suggested that if a catheter such as the Swan-Ganz continues to be used after the completion of a NG infusion, certain pharmacological effects due to the absorption of NG into the catheter body should be expected for at least 60 min.
authors.affiliation: Department of Cardiovascular Surgery, Iwaki Kyoritsu General Hospital, Fukushima, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Akiyama
authors.forename: J
authors.initials: J
authors.lastname: Hirota
authors.forename: M
authors.initials: M
authors.lastname: Takiguchi
authors.forename: S
authors.initials: S
authors.lastname: Ohsawa
authors.forename: A
authors.initials: A
authors.lastname: Hashimoto
mesh_terms: D000042:Absorption; D002405:Catheterization, Central Venous / Q000295:instrumentation*; D002408:Catheters, Indwelling; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D005996:Nitroglycerin / Q000008:administration & dosage / Q000009:adverse effects / Q000493:pharmacokinetics*; D012307:Risk Factors
chemical_list: D005996:Nitroglycerin